Safe and effective method of treating psoriatic arthritis with anti-IL-23 specific antibody

• 收藏
• 分享

专利权人:

Janssen Biotech; Inc.

发明人:

HSIA, Elizabeth,XU, Lillian

申请号：

AU2018360789

公开号：

AU2018360789A1

申请日:

2018.11.06

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

A method of treating psoriatic arthritis in a patient by administering an IL-23 specific antibody, e.g., guselkumab, in a clinically proven safe and clinically proven effective amount and the patient achieves significant ACR20/50/70, PASI70/90/100, MDA, HAQ-DI, SF-36 PCS, MCS, LEI/dactylitis, PASDAS, GRACE, mCPDAI, DAPSA or RAPID3 improvement as measured 16, 24, 32, 40 and 48 weeks after initial treatment.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/